AI-generated summary
The authors critically reviewed 89 clinical trials on melasma treatments published in English over the past 10 years, found through PubMed and MEDLINE. They report that topical hydroquinone and tranexamic acid showed promising results, that laser and light treatments were frequently studied, and that peels were not shown to be superior to topical therapy alone. The authors propose a stepwise treatment approach based on this evidence.
- Studies included
- 89
- Who or what was studied
- Patients with melasma, a common acquired facial pigmentation disorder, as studied in clinical trials
- Limits stated in the abstract
- The review searched only PubMed and MEDLINE, was limited to English-language articles, and the abstract does not describe a formal quality or certainty assessment of the included trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Contraindication. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.